References
1. Estrada CA, Young JA, Nifong LW, Chitwood WR Jr. Outcomes and
perioperative hyperglycemia in patients with or without diabetes
mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg.
2003;75(5):1392-99.
2. Anderson RE, Brismar K, Barr G, Ivert T. Effects of cardiopulmonary
bypass on glucose homeostasis after coronary artery bypass surgery. Eur
J Cardiothorac Surg. 2005;28(3):425-30.
3. Velissaris T, Tang AT, Murray M, Mehta RL, Wood PJ, Hett DA, Ohri SK.
A prospective randomized study to evaluate stress response during
beating-heart and conventional coronary revascularization. Ann Thorac
Surg. 2004;78(2):506-12.
4. Ouattara A, Lecomte P, Le Manach Y, Landi M, Jacqueminet S, Platonov
I, et al. Poor intraoperative blood glucose control is associated with a
worsened hospital outcome after cardiac surgery in diabetic patients.
Anesthesiology. 2005;103(4):687-94.
5. Doenst T, Wijeysundera D, Karkouti K, Zechner C, Maganti M, Rao V,
Borger MA. Hyperglycemia during cardiopulmonary bypass is an independent
risk factor for mortality in patients undergoing cardiac surgery. J
Thorac Cardiovasc Surg. 2005;130(4):1144.
6. Szabó Z, Håkanson E, Svedjeholm R. Early postoperative outcome and
medium-term survival in 540 diabetic and 2239 nondiabetic patients
undergoing coronary artery bypass grafting. Ann Thorac Surg.
2002;74(3):712-9.
7. McAlister FA, Man J, Bistritz L, Amad H, Tandon P. Diabetes and
coronary artery bypass surgery: an examination of perioperative glycemic
control and outcomes. Diabetes Care. 2003;26(5):1518-24.
8. Carvalho G, Moore A, Qizilbash B, Lachapelle K, Schricker T.
Maintenance of normoglycemia during cardiac surgery. Anesth Analg.
2004;99(2):319-24.
9. Subramaniam K, Sciortino C, Ruppert K, Monroe A, Esper S, Boisen M,
et al. Remifentanil and perioperative glycaemic response in cardiac
surgery: an open-label randomised trial. Br J Anaesth.
2020;124(6):684-92.
10. Lighthall GK, Singh S. Perioperative Maintenance of Tissue Perfusion
and Cardiac Output in Cardiac Surgery Patients. Semin Cardiothorac Vasc
Anesth. 2014;18(2):117-36.
11. J-OC Dunn, MG Mythen, MP Grocott. Physiology of oxygen
transport, BJA Education, 16(10): 341–348, 2016.
12. Duggan EW, Carlson K, Umpierrez GE. Perioperative Hyperglycemia
Management: An Update. Anesthesiology. 2017;126(3):547-560. Erratum in:
Anesthesiology. 2018 Nov;129(5):1053.
13. Huber W, Zanner R, Schneider G, Schmid R, Lahmer T. Assessment of
Regional Perfusion and Organ Function: Less and Non-invasive Techniques.
Front Med (Lausanne). 2019;6:50.
14. Schmeltz LR, DeSantis AJ, Thiyagarajan V, Schmidt K, O’Shea-Mahler
E, Johnson D, et al. Reduction of surgical mortality and morbidity in
diabetic patients undergoing cardiac surgery with a combined intravenous
and subcutaneous insulin glucose management strategy. Diabetes Care.
2007;30(4):823-8.
15. Mills NL, Beaudet RL, Isom OW, Spencer FC. Hyperglycemia during
cardiopulmonary bypass. Ann Surg. 1973;177(2):203-205.
16. Shen C, Gu T, Gu L, Xiu Z, Zhang Z, Shi E, et al. Change in the
perioperative blood glucose and blood lactate levels of non-diabetic
patients undergoing coronary bypass surgery. Exp Ther Med.
2013;6(5):1220-4.
17. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O’Brien PC,
et al. Intensive intraoperative insulin therapy versus conventional
glucose management during cardiac surgery: a randomized trial. Ann
Intern Med. 2007;146(4):233-43.
18. Hua J, Chen G, Li H, Hunt SL, Martin CT, Hebsur S, Ad N. Intensive
intraoperative insulin therapy versus conventional insulin therapy
during cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth.
2012;26(5):829-34.
19. Desai SP, Henry LL, Holmes SD, et al. Strict versus liberal target
range for perioperative glucose in patients undergoing coronary artery
bypass grafting: a prospective randomized controlled trial. J Thorac
Cardiovasc Surg. 2012 Feb;143(2):318-325. doi:
10.1016/j.jtcvs.2011.10.070.
20. Lazar HL, McDonnell MM, Chipkin S, Fitzgerald C, Bliss C, Cabral H.
Effects of aggressive versus moderate glycemic control on clinical
outcomes in diabetic coronary artery bypass graft patients. Ann Surg.
2011;254(3):458-63.
21. Pezzella AT, Holmes SD, Pritchard G, Speir AM, Ad N. Impact of
perioperative glycemic control strategy on patient survival after
coronary bypass surgery. Ann Thorac Surg. 2014 Oct;98(4):1281-1285. doi:
10.1016/j.athoracsur.2014.05.067.
22. Preiser JC, Chase JG, Hovorka R, Joseph JI, Krinsley JS, De Block C,
et al. Glucose Control in the ICU: A Continuing Story. J Diabetes Sci
Technol. 2016;10(6):1372-81.
23. Das S, Ghosh K, Hazra A, Sen C, Goswami A. Is elevated blood glucose
a marker of occult tissue hypoperfusion in off-pump coronary artery
bypass grafting? Ann Card Anaesth. 2018;21(4):393-401.
24. Sudy R, Petak F, Schranc A, Agocs S, Blaskovics I, Lengyel C, Babik
B. Differences Between Central Venous and Cerebral Tissue Oxygen
Saturation in Anaesthetised Patients With Diabetes Mellitus. Sci Rep.
2019; 24;9(1):19740.
25. Stephens EH, Epting CL, Backer CL, Wald EL. Hyperlactatemia: An
Update on Postoperative Lactate. World J Pediatr Congenit Heart Surg.
2020;11(3):316-24.
26. Maillet JM, Le Besnerais P, Cantoni M, Nataf P, Ruffenach A, Lessana
A, Brodaty D. Frequency, risk factors, and outcome of hyperlactatemia
after cardiac surgery. Chest. 2003;123(5):1361-6.
27. Greco G, Kirkwood KA, Gelijns AC, Moskowitz AJ, Lam DW. Diabetes Is
Associated With Reduced Stress Hyperlactatemia in Cardiac Surgery.
Diabetes Care. 2018;41(3):469-477.
Table 1: Demographic and clinical characteristics of the study
population